RxDoctor Payments Data

Janelle King, MD

Dermatology · Vienna, WVNPI 1386879138

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,579 of the $1,800 with a category attached, or 87.7%. 8 manufacturers reported payments, led by AbbVie at 57.4% of the total. That places this record below the midpoint for dermatology clinicians in WV, where the typical reported total is $2,210.

$1,800in general payments, 2019–2025

Across 72 payments — averaging $25.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • E.r. Squibb & Sons, L.L.C.$240
  • Regeneron Healthcare Solutions, Inc.$187
  • Novartis$105
  • Johnson & Johnson$100
  • UCB, Inc.$49
  • plus $86 from 2 others

What the payments were for

  • Food & beverage$1,57988%
  • Education$22112%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,800 in reported general payments places this provider in the 35th percentile of 39 dermatology providers in West Virginia.

See all dermatology providers in West Virginia

Medicare billing

Part B allowed, 2024
$253,751
Medicare patients
1,142
Services billed
3,449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OtezlaApremilast38$201,801
Humira(Cf) PenAdalimumab18$114,173
Dupixent PenDupilumab26$97,442
Dupixent SyringeDupilumab13$50,426
Clobetasol Propionate248$8,975
Imiquimod105$3,229
Triamcinolone Acetonide287$2,773
Fluorouracil38$2,460
Fluocinolone Acetonide40$2,005
Doxycycline Hyclate101$1,999
Fluocinonide42$1,709
Metronidazole34$1,610
Nystatin89$1,512
Ketoconazole106$1,282
Calcipotriene12$1,273

Paid to pharmacies, not to this prescriber.

Other dermatology in Vienna

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →